The role of vitamin D in skeletal and cardiac muscle function

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  Polly, Patsie ^a   Tan, Timothy C ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer cachexia; Cardiac muscle and transcriptome; Cytokines; Skeletal muscle

Indexed keywords

CALCITRIOL; CALCIUM; CELL NUCLEUS RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BONE METABOLISM; CACHEXIA; CALCIUM SIGNALING; CHRONIC INFLAMMATION; FIBROSIS; GENE TARGETING; HEART MUSCLE; HUMAN; HUMAN TISSUE; INFLAMMATION; MUSCLE FUNCTION; MUSCLE METABOLISM; MYOPATHY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; SYSTEMS BIOLOGY;

EID: 84901032953     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00145     Document Type: Article

References (89)

1. Ahmed, W., Khan, N., Glueck, C. J., Pandey, S., Wang, P., Goldenberg, N., et al. (2009). Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl. Res. 153, 11-16. doi: 10.1016/j.trsl.2008.11.002
2. Argiles, J. M., Moore-Carrasco, R., Fuster, G., Busquets, S., and Lopez-Soriano, F. J. (2003). Cancer cachexia: the molecular mechanisms. Int. J. Biochem. Cell Biol. 35, 405-409. doi: 10.1016/S1357-2725(02)00251-0
3. Asp, M. L., Tian, M., Wendel, A. A., and Belury, M. A. (2010). Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int. J. Cancer 126, 756-763. doi: 10.1002/ijc.24784
4. Baltgalvis, K. A., Berger, F. G., Pena, M. M., Davis, J. M., Muga, S. J., and Carson, J. A. (2008). Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R393-R401. doi: 10.1152/ajpregu.00716.2007
5. Bischoff-Ferrari, H. A., Borchers, M., Gudat, F., Durmuller, U., Stahelin, H. B., and Dick, W. (2004). Vitamin D receptor expression in human muscle tissue decreases with age. J. Bone Miner. Res. 19, 265-269. doi: 10.1359/jbmr.2004.19.2.265
6. Bischoff-Ferrari, H. A., Conzelmann, M., Stahelin, H. B., Dick, W., Carpenter, M. G., Adkin, A. L., et al. (2006). Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos. Int. 17, 656-663. doi: 10.1007/s00198-005-0030-9
7. 3 receptor in human skeletal muscle tissue. Histochem. J. 33, 19-24. doi: 10.1023/A:1017535728844
8. Boland, R. (1986). Role of vitamin D in skeletal muscle function. Endo. Rev. 7, 434-448. doi: 10.1210/edrv-7-4-434
9. 3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J. Steroid Biochem. Mol. Biol. 121, 169-175. doi: 10.1016/j.jsbmb.2010.03.002
10. 3 in C2C12 skeletal muscle cells. Mol. Cell. Endocrinol. 339, 81-89. doi: 10.1016/j.mce.2011.03.022
11. Buitrago, C., Vazquez, G., De Boland, A. R., and Boland, R. (2001). The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3). Biochem. Biophys. Res. Commun. 289, 1150-1156. doi: 10.1006/bbrc.2001.6072
12. Burne, T. H., McGrath, J. J., Eyles, D. W., and Mackay-Sim, A. (2005). Behavioural characterization of vitamin D receptor knockout mice. Behav. Brain Res. 157, 299-308. doi: 10.1016/j.bbr.2004.07.008
13. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell. Biochem. 86, 128-135. doi: 10.1002/jcb.10191
14. Carson, J. A., and Baltgalvis, K. A. (2010). Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc. Sport Sci. Rev. 38, 168-76. doi: 10.1097/JES.0b013e3181f44f11
15. Ceglia, L., da Silva Morais, M., Park, L. K., Morris, E., Harris, S. S., Bischoff-Ferrari, H. A., et al. (2010). Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J. Mol. Histol. 41, 137-142. doi: 10.1007/s10735-010-9270-x
16. Chen, S., and Gardner, D. G. (2013). Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart. J. Steroid Biochem. Mol. Biol. 136, 150-155. doi: 10.1016/j.jsbmb.2012.09.007
17. Choi, M., Park, H., Cho, S., and Lee, M. (2013). Vitamin D3 supplementation modulates inflammatory responses from the muscle damage induced by high-intensity exercise in SD rats. Cytokine 63, 27-35. doi: 10.1016/j.cyto.2013.03.018
18. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119, 2214-2220. doi: 10.1210/endo-119-5-2214
19. Dahele, M., Skipworth, R. J. E., Wall, L., Voss, A., Preston, T., and Fearon, K. C. H. (2007). Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J. Pain Symptom Manage. 33, 676-685. doi: 10.1016/j.jpainsymman.2006.09.024
20. DeLuca, H. F. (2004). Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80, 1689S-1696S.
21. Dev, R., Del Fabbro, E., Schwartz, G. G., Hui, D., Palla, S. L., Gutierrez, N., et al. (2011). Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist 16, 1637-1641. doi: 10.1634/theoncologist.2011-0151
22. Eggersdorfer, M., and Stöcklin, E. (2013). Vitamin D, an essential nutrient with versatile functions in nearly all organs. Int. J. Vitam Nutr. Res. 83, 92-100. doi: 10.1024/0300-9831/a000151
23. Endo, I., Inoue, D., Mitsui, T., Umaki, Y., Akaike, M., Yoshizawa, T., et al. (2003). Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144, 5138-5144. doi: 10.1210/en.2003-0502
24. Endo, K., Katsumata, K., Iguchi, H., Kubodera, N., Teramoto, T., Ikeda, K., et al. (1998). Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia. J. Bone Miner. Res. 13, 1378-1383. doi: 10.1359/jbmr.1998.13.9.1378
25. Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., et al. (2008). Cachexia: a new definition. Clin. Nutr. 27, 793-799. doi: 10.1016/j.clnu.2008.06.013
26. Falconer, R., Tan, T. C., and Polly, P. (in press). Autophagy and cardiac dysfunction in cancer cachexia. World J. Can. Res.
27. Fearon, K. C. H. (2008). Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur. J. Cancer 44, 1124-1132. doi: 10.1016/j.ejca.2008.02.033
28. Fukuda, T., Sumi, T., Nobeyama, H., Yoshida, H., Matsumoto, Y., Yasui, T., et al. (2009). Multiple organ failure of tumur-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells. Int. J. Oncol. 34, 61-67.
29. 3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152, 2976-2986. doi: 10.1210/en.2011-0159
30. Girgis, C. M., Cheng, K., Scott, C. H., and Gunton, J. E. (2012). Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol. Metab. 23372-23380. doi: 10.1016/j.tem.2012.05.003
31. Girgis, C. M., Clifton-Bligh, R. J., Hamrick, M. W., Holick, M. F., and Gunton, J. E. (2013). The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocrine Rev. 34, 33-83. doi: 10.1210/er.2012-1012
32. Girgis, C. M., Clifton-Bligh, R. J., Mokbel, N., Cheng, K., and Gunton, J. E. (2014). Vitamin D Signaling Regulates Proliferation, Differentiation, and Myotube Size in C2C12 Skeletal Muscle Cells. Endocrinology 155, 347-357. doi: 10.1210/en.2013-1205
33. Girgis, C. M., Clifton-Bligh, R. J., Turner, N., Lau, S. L., and Gunton, J. E. (2014). Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin. Endocrinol. 80, 169-181. doi: 10.1111/cen.12368
34. Glerup, H., and Eriksen, E. F. (1999). Acroparaesthesia-a typical finding in vitamin D deficiency. Rheumatology 38, 482. doi: 10.1093/rheumatology/38.5.482
35. Glerup, H., Mikkelsen, K., Poulsen, L., Hass, E., Overbeck, S., Andersen, H., et al. (2000). Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcified Tissue Int. 66, 419-424. doi: 10.1007/s002230010085
36. Grimaldi, A. S., Parker, B. A., Capizzi, J. A., Clarkson, P. M., and Pescatello, L. S., White, M. C., et al. (2013). 25(OH) vitamin D is associated with greater muscle strength in healthy men and women. Med. Sci. Sports Exerc. 45, 157-162. doi: 10.1249/MSS.0b013e31826c9a78
37. Haddad, F., Zaldivar, F., Cooper, D. M., and Adams, G. R. (2005). IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98, 911-917. doi: 10.1152/japplphysiol.01026.2004
38. Hellerstein, H. K., and Santiago-Stevenson, D. (1950). Atrophy of the heart: a correlative study of eighty-five proved cases. Circulation 1, 93-126. doi: 10.1161/01.CIR.1.1.93
39. Jackman, R. W., and Kandarian, S. C. (2004). The molecular basis of skeletal muscle atrophy. Am. J. Physiol. Cell Physiol. 287, C834-C843. doi: 10.1152/ajpcell.00579.2003
40. Koleganova, N., Piecha, G., Ritz, E., and Gross, M.-L. (2009). Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol. Dial. Transplant. 24, 778-787. doi: 10.1093/ndt/gfn549
41. Ludolph, D. C., and Konieczny, S. F. (1995). Transcription factor families: muscling in on the myogenic program. FASEB J. 9, 1595-1604.
42. Luna, N. D., Diaz-Manera, J., Paradas, C., Iturriaga, C., Rojas-Garcia, R., Araque, J., et al. (2012). 1alpha,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial. Mol. Ther. 20, 1988-1997. doi: 10.1038/mt.2012.156
43. 3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol. Genom. 29, 161-168.
44. Mantovani, G., Macciò, A., Madeddu, C., Gramignano, G., Serpe, R., Massa, E., et al. (2008). Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 24, 305-313. doi: 10.1016/j.nut.2007.12.010
45. Marcinkowska, E. (2001). A run for a membrane vitamin D receptor. Biol. Signals Recept. 10, 341-349. doi: 10.1159/000046902
46. Marin-Corral, J., Fontes, C. C., Pascual-Guardia, S., Sanchez, F., Olivan, M., Argilés, J. M., et al. (2010). Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid. Redox Signal. 12, 365-380. doi: 10.1089/ars.2009.2818
47. Matsumoto, T., Fujimoto-Ouchi, K., Tamura, S., Tanaka, Y., and Ishitsuka, H. (1999). Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma. Br. J. Cancer 79, 764-769. doi: 10.1038/sj.bjc.6690123
48. Meems, L. M., van der Harst, P., van Gilst, W. H., de Boer, R. A. (2011). Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr. Drug Targets 12, 29-41. doi: 10.2174/138945011793591554
49. Michael, M., and Tannock, I. F. (1998). Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 158, 1727-1734.
50. 3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1. Int. J. Oncol. 27, 893-900.
51. Morley, J. E. (2009). Calories and cachexia. Curr. Opin. Clin. Nutr. Metab. Care 12, 607-610. doi: 10.1097/MCO.0b013e328331e9ce
52. Morley, J. E., Anker, S. D., and Evans, W. J. (2009). Cachexia and aging: an update based on the Fourth International Cachexia Meeting. J. Nutr. Health Aging 13, 47-55. doi: 10.1007/s12603-009-0009-x
53. Nowak, R., Szota, J., and Mazurek, U. (2012). Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients. BMC Musculoskelet. Disord. 13, 259. doi: 10.1186/1471-2474-13-259
54. Perry, R. L. S., and Rudnicki, M. A. (2000). Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 5, D750-D767.
55. Pfeifer, M., Begerow, B., and Minne, H. W. (2002). Vitamin D and muscle function. Osteoporosis Int. 13, 187-194. doi: 10.1007/s001980200012
56. Punzi, T., Fabris, A., Morucci, G., Biagioni, P., Gulisano, M., Ruggiero, M., et al. (2012). C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients. Mol. Diagnosis Ther. 16, 115-124. doi: 10.2165/11632380-000000000-00000
57. Rejnmark, L. (2011). Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials. Ther. Adv. Chronic Dis. 2, 25-37. doi: 10.1177/2040622310381934
58. Rodman, J. S., and Baker, T. (1978). Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int. 13, 189-193. doi: 10.1038/ki.1978.28
59. Rudkowska, I., Jacques, H., Weisnagel, S. J., Marette, A., and Vohl, M. C. (2013). Transcriptomic profiles of skeletal muscle tissue following an euglycemic-hyperinsulinemic clamp in insulin-resistant obese subjects. Genes Nutr. 8, 91-98. doi: 10.1007/s12263-012-0298-2
60. 3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. Biochem. Pharmacol. 66, 495-504.
61. Santillan, G., Katz, S., Vazquez, G., and Boland, R. L. (2004). TRPC3-like protein and vitamin D receptor mediate 1alpha,25(OH)2D3-induced SOC influx in muscle cells. Int. J. Biochem. cell Biol. 36, 1910-1918. doi: 10.1016/j.biocel.2004.01.027
62. Sato, K., Onuma, E., Yocum, R. C., and Ogata, E. (2003). Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody. Semin. Oncol. 30, 167-173. doi: 10.1053/j.seminoncol.2003.08.019
63. Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. (2005). Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc. Dis. 20, 187-192. doi: 10.1159/000087203
64. Schott, G. D., and Wills, M. R. (1976). Muscle weakness in osteomalacia. Lancet 1, 626-629. doi: 10.1016/S0140-6736(76)90428-1
65. Schwarzkopf, M., Coletti, D., Sassoon, D., and Marazzi, G. (2006). Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev. 20, 3440-3452. doi: 10.1101/gad.412606
66. Shum, A. M., Mahendradatta, T., Taylor, R. J., Painter, A. B., Moore, M. M., Tsoli, M., et al. (2012). Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging 4, 133-143.
67. Shum, A. M., Tan, T. C., and Polly, P. (2013). A comparative study of gene expression changes in skeletal and cardiac muscle from the colon 26 carcinoma mouse model of cachexia:identification of common molecular targets for future intervention studies. World J. Cancer Res. 1, 69-77.
68. 3 receptors and activities in muscle. J. Biol. Chem. 260, 8882-8891.
69. Skaria, J., Katiyar, B. C., Srivastava, T. P., and Dube, B. (1975). Myopathy and neuropathy associated with osteomalacia. Acta Neurol. Scand. 51, 37-58. doi: 10.1111/j.1600-0404.1975.tb01358.x
70. Song, Y., Kato, S., and Fleet, J. C. (2003). Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J. Nutr. 133, 374-380.
71. Sorensen, O. H., Lund, B., Saltin, B., Lund, B., Andersen, R. B., Hjorth, L., et al. (1979). Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin. Sci. 56, 157-161.
72. Springer, J., Hartmann, A., Palus, S., Grzesiak, A., Aaschia, E., and Anker, S. D. (2009). Development of severe progressive heart failure in experimental cancer cachexia. J. Card. Fail. 15, S25-S25. doi: 10.1016/j.cardfail.2009.06.391
73. Srikuea, R., Zhang, X., Park-Sarge, O. K., and Esser, K. A. (2012). VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am. J. Physiol. Cell Physiol. 303, C396-C405. doi: 10.1152/ajpcell.00014.2012
74. Stentz, F. B., and Kitabchi, A. E. (2007). Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 5, 216-235. doi: 10.1016/S1672-0229(08)60009-1
75. Stewart, C. E., and Rittweger, J. (2006). Adaptive processes in skeletal muscle: molecular regulators and genetic influences. J. Musculoskelet. Neuronal Interact. 6, 73-86.
76. Strassmann, G., Fong, M., Kenney, J. S., and Jacob, C. O. (1992). Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89, 1681-1684. doi: 10.1172/JCI115767
77. Stratos, I., Li, Z., Herlyn, P., Rotter, R., Behrendt, A. K., Mittlmeier, T., et al. (2013). Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. Am. J. Pathol. 182, 895-904. doi: 10.1016/j.ajpath.2012.11.006
78. Strohle, A., Zanker, K., and Hahn, A. (2010). Nutrition in oncology: the case of micronutrients (review). Oncol. Rep. 24, 815-828. doi: 10.3892/or.2010.815
79. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., et al. (1990). Experimental cancer cachexia induced by transplantable colon 26 Adenocarcinoma in mice. Cancer Res. 50, 2290-2295.
80. Tan, T. C., Gupta, S., Shum, A. M. Y., and Polly, P. (2013). The Role of IL-6 and Myogenic transcription factors in skeletal muscle wasting and dysfunction due to cancer cachexi. World J. Cancer Res. 1, 15-23.
81. Tian, M., Nishijima, Y., Asp, M. L., Stout, M. B., Reiser, P. J., and Belury, M. A. (2010). Cardiac alterations in cancer-induced cachexia in mice. Int. J. Oncol. 37, 347-353.
82. Tisdale, M. J. (2009). Mechanisms of cancer cachexia. Physiol. Rev. 89, 381-410. doi: 10.1152/physrev.00016.2008
83. Tishkoff, D. X., Nibbelink, K. A., Holmberg, K. H., Dandu, L., and Simpson, R. U. (2008). Functional Vitamin D Receptor (VDR) in the T-tubules of cardiac myocytes: VDR Knockout cardiomyocyte contractility. Endocrinology 149, 558-564. doi: 10.1210/en.2007-0805
84. 3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest. Prostate 71, 98-110. doi: 10.1002/pros.21226
85. 3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111, 1666-1671. doi: 10.1161/01.CIR.0000160353.27927.70
86. 3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Invest. 97, 1577-1588. doi: 10.1172/JCI118582
87. Yoshikawa, S., Nakamura, T., Tanabe, H., and Imamura, T. (1979). Osteomalacic myopathy. Endocrinol. Japonica 26, 65-72. doi: 10.1507/endocrj1954.26.Supplement_65
88. 3 Suppresses Renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282, 29821-29830. doi: 10.1074/jbc.M705495200
89. Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., et al. (2010). Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543. doi: 10.1016/j.cell.2010.07.011